Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

盘后交易 07-23 19:59:33 EDT

3.34

+0.53

+18.89%

盘后3.30

-0.04-1.06%

19:58 EDT

最高3.85	最低2.70	成交量4,389万
今开2.74	昨收2.81	日振幅41.00%
总市值2.57亿	流通市值1.77亿	总股本7,709万
成交额1.48亿	换手率82.47%	流通股本5,322万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":3.335,"timestamp":1753300800000,"preClose":2.805,"halted":0,"volume":43887693,"hourTrading":{"tag":"盘后","latestPrice":3.2995,"preClose":3.335,"latestTime":"19:58 EDT","volume":220136,"amount":712921.002528,"timestamp":1753315130892},"delay":0,"floatShares":53219212,"shares":77086750,"eps":-3.069566,"marketStatus":"盘后交易","change":0.53,"latestTime":"07-23 19:59:33 EDT","open":2.74,"high":3.85,"low":2.7,"amount":147954322.304679,"amplitude":0.409982,"askPrice":3.3,"askSize":242,"bidPrice":3.27,"bidSize":665,"shortable":0,"etf":0,"ttmEps":-3.069566,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753315200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":2.805,"preHourTrading":{"tag":"盘前","latestPrice":2.75,"preClose":2.805,"latestTime":"09:29 EDT","volume":783998,"amount":2161053.8742934,"timestamp":1753277394807},"postHourTrading":{"tag":"盘后","latestPrice":3.2995,"preClose":3.335,"latestTime":"19:58 EDT","volume":220136,"amount":712921.002528,"timestamp":1753315130892},"volumeRatio":2.157861,"optionData":{"bulkOrders":[{"symbol":"REPL","call":true,"expireDate":1758254400000,"strike":"5.0","timestamp":1753288685132,"price":0.33,"volume":2384,"amount":78672,"type":"+"},{"symbol":"REPL","call":true,"expireDate":1758254400000,"strike":"5.0","timestamp":1753288685132,"price":0.32,"volume":2384,"amount":76288,"type":"+"}]},"impliedVol":1.3414,"impliedVolPercentile":0.828},"requestUrl":"/m/hq/s/REPL","defaultTab":"news","newsList":[{"id":"1106132014","title":"异动解读 | Replimune集团股价夜盘反弹5.53%，此前因新药被拒暴跌超70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106132014","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106132014?lang=zh_cn&edition=full","pubTime":"2025-07-23 08:14","pubTimestamp":1753229674,"startTime":"0","endTime":"0","summary":"美股夜盘交易中，Replimune集团股价上涨5.53%，呈现出小幅反弹。这一反弹发生在该公司股价白天暴跌超过70%之后，反映出投资者情绪的波动。Replimune集团股价的剧烈波动源于一则重大利空消息。FDA表示，Replimune的临床试验\"不被认为是一项充分且控制良好的临床研究，无法提供实质性的有效性证据\"。作为一家专注于开发免疫疗法的生物技术公司，Replimune集团此次新药申请的被拒对其发展战略产生了重大影响。公司表示将紧急与FDA沟通，以寻求解决方案。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["REPL"],"gpt_icon":1},{"id":"1138283909","title":"盘前丨加密货币概念股多数上涨，IREN Ltd涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138283909","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138283909?lang=zh_cn&edition=full","pubTime":"2025-07-22 21:00","pubTimestamp":1753189241,"startTime":"0","endTime":"0","summary":"个股方面：加密货币概念股盘前多数上涨，$IREN Ltd$涨超5%、 Upexi、 $特朗普媒体科技集团$涨超3%，$Galaxy Digital$、$嘉楠科技$涨超2%。第二季度调整后息税前利润30.4亿美元，同比下降32%。Replimune暴跌77%，FDA拒绝批准该公司的皮肤癌药物。资本分配方面，向股东返还9亿美元并上调股息8%。上半年总营收 194.41 亿美元，同比 2024 年上半年 182.61 亿美元增长 6.5%。哈里伯顿盘前下跌0.85%，二季度总营收 55 亿美元，同比下滑 5.7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/26e574706ced777ba0af741c0072c424","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/26e574706ced777ba0af741c0072c424"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOM.USD.HKCC","DEFI","UNI.USD.CC","BITO","BRRR","FBTC","COMP.USD.HKCC","REPL","UNI.USD.HKCC","BTCO","DYDX.USD.HKCC","MKR.USD.CC","VBTC.AU","LTC.USD.HKCC","LDO.USD.HKCC","APT.USD.CC","EZBC","SNX.USD.HKCC","AVAX.USD.CC","IREN","TON.USD.CC"],"gpt_icon":0},{"id":"1149643878","title":"异动解读 | Replimune集团股价盘前暴跌75.74%，FDA拒绝批准其皮肤癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1149643878","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149643878?lang=zh_cn&edition=full","pubTime":"2025-07-22 20:22","pubTimestamp":1753186961,"startTime":"0","endTime":"0","summary":"Replimune集团今日盘前股价暴跌75.74%，引发市场震动。这一大幅下跌主要源于美国食品和药物管理局拒绝批准该公司的实验性皮肤癌药物RP1。FDA还指出，由于患者群体的异质性，该试验结果无法得到充分解释。这一决定对Replimune的新药开发计划造成了重大打击，直接导致其股价大幅下挫。面对这一挫折，Replimune集团表示计划与FDA进行紧急互动，以寻找前进的道路。然而，此次FDA的决定无疑给公司的研发进程蒙上了一层阴影，投资者对公司前景的信心受到严重打击。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["REPL"],"gpt_icon":0},{"id":"2551196682","title":"Replimune Group, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551196682?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:11","pubTimestamp":1752595917,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时11分，Replimune Group, Inc.股票出现波动，股价快速上涨5.05%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2035.91%、1922.78%、1531.94%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为416.92%、109.47%、75.50%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160011579543aeeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160011579543aeeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2550865659","title":"Replimune Group, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550865659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550865659?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:02","pubTimestamp":1752069770,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时02分，Replimune Group, Inc.股票出现波动，股价大幅上涨5.03%。截至发稿，该股报9.81美元/股，成交量26.7345万股，换手率0.35%，振幅3.64%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为760.27%、647.64%、480.29%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Calidi Biotherapeutics, Inc.、Prokidney Corp.，振幅分别为112.02%、59.70%、48.79%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220250979fbd1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220250979fbd1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2549214556","title":"Replimune Group, Inc.盘中异动 临近午盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549214556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549214556?lang=zh_cn&edition=full","pubTime":"2025-07-07 23:38","pubTimestamp":1751902734,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日23时38分，Replimune Group, Inc.股票出现波动，股价急速拉升5.00%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。消息层面，截至23时38分，《H.C. Wainwright维持Replimune买入评级，维持目标价22美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707233855a69b44ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707233855a69b44ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2546258229","title":"Replimune Group, Inc.盘中异动 临近收盘快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546258229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546258229?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:47","pubTimestamp":1750794426,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时47分，Replimune Group, Inc.股票出现异动，股价大幅上涨5.09%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大，Eyenovia, Inc.、Nucana Plc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1426.78%、1042.90%、548.70%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Immatics N V C/Wts 01/07/2025 、内克塔治疗，振幅分别为191.38%、156.58%、116.56%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625034707a4bbfdba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625034707a4bbfdba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2544120425","title":"Replimune Group(REPL.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544120425","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544120425?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:21","pubTimestamp":1750425661,"startTime":"0","endTime":"0","summary":"Replimune Group(REPL.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/20212151211292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["REPL"],"gpt_icon":0},{"id":"2542181534","title":"Replimune Group, Inc.盘中异动 下午盘快速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542181534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542181534?lang=zh_cn&edition=full","pubTime":"2025-06-12 02:26","pubTimestamp":1749666419,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日02时26分，Replimune Group, Inc.股票出现异动，股价大幅跳水5.13%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Kazia Therapeutics Limited、Synaptogenix, Inc.、Jupiter Neurosciences, Inc.涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为11992.06%、3444.99%、202.42%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kazia Therapeutics Limited，振幅分别为88.67%、84.50%、79.16%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612022659a7040382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612022659a7040382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2541586261","title":"Replimune Group, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541586261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541586261?lang=zh_cn&edition=full","pubTime":"2025-06-07 01:10","pubTimestamp":1749229848,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日01时10分，Replimune Group, Inc.股票出现波动，股价快速拉升5.03%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Phathom Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为3323.73%、829.60%、87.70%，振幅较大的相关个股有Phathom Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Klotho Neurosciences, Inc.，振幅分别为162.26%、99.50%、58.69%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607011048a6fd7614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607011048a6fd7614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2540061630","title":"Replimune Group, Inc.盘中异动 快速上涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540061630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540061630?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:40","pubTimestamp":1749044405,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时40分，Replimune Group, Inc.股票出现异动，股价急速上涨5.34%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Cellectar Biosciences, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Nutriband Inc C/Wts 涨幅较大，Nucana Plc、Conduit Pharmaceuticals Inc.、Cellectar Biosciences, Inc.较为活跃，换手率分别为623.14%、516.35%、304.06%，振幅较大的相关个股有Cellectar Biosciences, Inc.、知临集团、Rapport Therapeutics, Inc.，振幅分别为20.89%、15.46%、13.73%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604214005a6fa5b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604214005a6fa5b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2540799977","title":"Piper Sandler：维持Replimune Group(REPL.US)评级，由增持调整至增持评级, 目标价由14.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540799977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540799977?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:25","pubTimestamp":1748874319,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Replimune Group(REPL.US)评级，由增持调整至增持评级, 目标价由14.00美元调整至22.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/02222550812700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["REPL"],"gpt_icon":0},{"id":"2540795570","title":"Replimune Group, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795570?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:32","pubTimestamp":1748871149,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时32分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.01%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Vera Therapeutics, Inc.涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为976.18%、558.26%、260.59%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Nutriband Inc C/Wts 、Opus Genetics, Inc.，振幅分别为72.82%、41.96%、27.15%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213229950b944d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213229950b944d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2539278598","title":"Replimune Group, Inc.盘中异动 早盘快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278598?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:40","pubTimestamp":1748612409,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时40分，Replimune Group, Inc.股票出现异动，股价快速跳水5.02%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为3.28%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Bioline Rx Ltd、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃，换手率分别为346.41%、153.37%、85.84%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Bioline Rx Ltd，振幅分别为49.50%、37.35%、26.90%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053021400995084f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053021400995084f4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2538648454","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538648454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538648454?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:31","pubTimestamp":1748352668,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分，Replimune Group, Inc.股票出现异动，股价急速拉升5.09%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Gyre Therapeutics, Inc.、Dbv Technologies涨幅较大，Nucana Plc、Bioxcel Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为202.28%、73.92%、68.53%，振幅较大的相关个股有Polyrizon Ltd.、Fibrobiologics, Inc.、天境生物，振幅分别为15.33%、6.17%、6.04%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213108a6ef030b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213108a6ef030b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2538194851","title":"Replimune Group, Inc.2025财年实现净利润-2.47亿美元，同比减少14.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538194851","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538194851?lang=zh_cn&edition=full","pubTime":"2025-05-25 00:00","pubTimestamp":1748102441,"startTime":"0","endTime":"0","summary":"5月25日，Replimune Group, Inc.公布财报，公告显示公司2025财年净利润为-2.47亿美元，同比减少14.35%；其中营业收入为0.00美元，每股基本收益为-3.07美元。从资产负债表来看，Replimune Group, Inc.总负债1.35亿美元，其中短期债务3.98百万美元，资产负债比为4.09，流动比率为0.08。机构评级：截至2025年5月25日，当前有7家机构对Replimune Group, Inc.目标价做出预测，其中目标均价为21.86美元，其中最低目标价为16.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525000221a48af0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525000221a48af0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL"],"gpt_icon":0},{"id":"2537132437","title":"Replimune Group, Inc.盘中异动 早盘急速跳水5.25%报8.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537132437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537132437?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:33","pubTimestamp":1748007236,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时33分，Replimune Group, Inc.股票出现异动，股价大幅下跌5.25%。截至发稿，该股报8.30美元/股，成交量9.5808万股，换手率0.12%，振幅4.45%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Imunon, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1134.12%、1110.67%、352.48%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为40.00%、38.51%、25.25%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213356a6ea5ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213356a6ea5ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2537942811","title":"Replimune Group, Inc.盘中异动 早盘股价大涨7.30%报9.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537942811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537942811?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:31","pubTimestamp":1747920675,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时31分，Replimune Group, Inc.股票出现异动，股价急速拉升7.30%。截至发稿，该股报9.08美元/股，成交量6.0032万股，换手率0.08%，振幅0.59%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1214.96%、795.89%、328.75%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Aura Biosciences, Inc.、Apogee Therapeutics, Inc.，振幅分别为24.71%、8.99%、6.50%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213115a6e8f140&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213115a6e8f140&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2536641123","title":"Replimune Group, Inc.盘中异动 早盘快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536641123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536641123?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:17","pubTimestamp":1747754248,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时17分，Replimune Group, Inc.股票出现异动，股价急速上涨5.06%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为3871.98%、1471.37%、991.02%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.，振幅分别为174.55%、95.65%、85.46%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052023172894fcd90c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052023172894fcd90c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRXS","REPL","BK4082"],"gpt_icon":0},{"id":"2536347926","title":"Replimune Group, Inc.盘中异动 大幅拉升5.10%报8.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536347926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536347926?lang=zh_cn&edition=full","pubTime":"2025-05-20 02:31","pubTimestamp":1747679472,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日02时31分，Replimune Group, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报8.25美元/股，成交量48.4094万股，换手率0.63%，振幅9.62%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Armata Pharmaceuticals, Inc.涨幅较大，Protagenic Therapeutics, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为14563.03%、10580.21%、2750.74%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Armata Pharmaceuticals, Inc.，振幅分别为862.26%、236.96%、109.63%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520023113975e964b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520023113975e964b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":-0.7738},{"period":"1month","weight":-0.6974},{"period":"3month","weight":-0.6823},{"period":"6month","weight":-0.796},{"period":"1year","weight":-0.7149},{"period":"ytd","weight":-0.7684}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.1745},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.1338},{"period":"ytd","weight":0.073}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.023803},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.070613},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.10067},{"month":4,"riseRate":0.571429,"avgChangeRate":0.118692},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.048711},{"month":6,"riseRate":0.857143,"avgChangeRate":0.223071},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.153406},{"month":8,"riseRate":0.428571,"avgChangeRate":0.059963},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.031249},{"month":10,"riseRate":0.571429,"avgChangeRate":0.117506},{"month":11,"riseRate":0.571429,"avgChangeRate":0.0375},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.09546}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}